Sagris, M.; Theofilis, P.; Antonopoulos, A.S.; Oikonomou, E.; Tsioufis, K.; Tousoulis, D.
Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand? Biomedicines 2022, 10, 242.
https://doi.org/10.3390/biomedicines10020242
AMA Style
Sagris M, Theofilis P, Antonopoulos AS, Oikonomou E, Tsioufis K, Tousoulis D.
Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand? Biomedicines. 2022; 10(2):242.
https://doi.org/10.3390/biomedicines10020242
Chicago/Turabian Style
Sagris, Marios, Panagiotis Theofilis, Alexios S. Antonopoulos, Evangelos Oikonomou, Kostas Tsioufis, and Dimitris Tousoulis.
2022. "Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?" Biomedicines 10, no. 2: 242.
https://doi.org/10.3390/biomedicines10020242
APA Style
Sagris, M., Theofilis, P., Antonopoulos, A. S., Oikonomou, E., Tsioufis, K., & Tousoulis, D.
(2022). Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand? Biomedicines, 10(2), 242.
https://doi.org/10.3390/biomedicines10020242